SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec gets Award notification from Pan American Health Organization

12 Nov 2025 Evaluate

Panacea Biotec has received an Award notification from Pan American Health Organization, (PAHO) Regional Office of World Health Organization under a Long-term agreement for supply of Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenzae type B (DTP-HepB-Hib) Vaccine (Pentavalent) - Liquid (single dose) (Easyfive-TT) to PAHO, valid until December 31, 2027.

The total award to the company is for supply of Easyfive-TT Vaccine aggregating around $4.75 million (around Rs.41 crore) during Calendar Year 2026 and 2027.

Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.


Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×